Leukemia Clinical Trials

Showing 4081-4100 of 10,987 trials

Not Yet Recruiting

Prediction Model for Early Biliary Stasis After Bariatric Surgery

NCT06385860

Developing and validating a predictive model to estimate the risk of early biliary stasis following bariatric surgery

ObesityDiabetesGallstones+1 more

China-Japan Friendship Hospital200 participantsStarted Jul 2024

COMPLETED

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

NCT06392763

This retrospective cohort study, based on the French medico-administrative database (SNDS), evaluated the care pathway, the effectiveness of management and the costs associated with patients treated with chimeric antigen receptor (CAR) T cells (CART-cells) (KYMRIAH or YESCARTA): paediatric and young adult patients (up to and including 25 years of age) with acute lymphoblastic leukaemia (ALL); and adult patients (18 years of age or older) with DLBCL.

Diffuse Large B-cell LymphomaAcute Lymphoblastic Leukemia (ALL)

Novartis Pharmaceuticals602 participantsStarted Aug 2021

Rueil-Malmaison, France

Not Yet RecruitingPhase 2

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

NCT06391008

This is an open label, prospective, single center Phase II clinical study. Intended to evaluate the main pathological response rate (MPR) and safety of stereotactic immunosensitized radiotherapy combined with Evoximab (PD-1/VEGF-A bispecific antibody) and chemotherapy neoadjuvant therapy for stage II-III NSCLC. Simultaneously observe and evaluate the complete pathological response rate (pCR), R0 resection rate, and event free survival (EFS) of stage II-III NSCLC treated with stereotactic radiotherapy combined with Evoximab (PD-1/VEGF-A bispecific antibody) and chemotherapy. Exploratory analysis based on serum/tumor molecular biological markers, as well as the optimal response time and mechanism for combined response.

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School44 participantsStarted Apr 2024

Prediction Model for Early Biliary Stasis After Bariatric Surgery

Care Pathway and Associated Costs of Patients Treated With CAR T-cells Based on SNDS Data

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Related Searches

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

Closed-loop tDCS in Patients in Minimally Conscious State

A Retrospective Cohort Study of 15 Cases of Pelvic Fractures Complicated by Morel-Lavallee Lesion

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

Dietary Intervention in Food Allergy

CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL

Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy

SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma

Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

Return of Aspiration-Free Swallow After Laryngotracheal Anesthesia

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Community-based Intervention Effects on Older Adults' Physical Activity